TL

Tina Larson

President and Chief Operating Officer

Recursion Pharmaceuticals

Therapeutic Areas

Recursion Pharmaceuticals Pipeline

DrugIndicationPhase
REC-4881Familial Adenomatous PolyposisPhase 2
REC-617Advanced Solid TumorsPhase 1/2
REC-1245Biomarker-enriched Solid Tumors and LymphomaPhase 1
REC-3565B-cell MalignanciesPhase 1
REC-4539Solid Tumors and Hematology OncologyPreclinical
Undisclosed ProgramSolid Tumors incl. HR+ Breast CancerPreclinical